Description

Maven Regulatory Solutions is proud to announce its participation in the BIO International Convention 2026, taking place from 22–25 June 2026 in San Diego, California, USA.

As the world's largest biotechnology convention, BIO 2026 brings together biotechnology companies, pharmaceutical leaders, investors, research organizations, regulatory authorities, CDMOs, CROs, and healthcare innovators from across the globe. The convention serves as a premier platform for exploring emerging technologies, strategic partnerships, licensing opportunities, investment trends, and the future of life sciences.

This year's BIO agenda highlights how artificial intelligence, cell & gene therapies, precision medicine, biologics, and next-generation healthcare innovations are transforming drug development while accelerating commercialization and global collaborations.

Maven Regulatory Solutions – Global Regulatory & Life Sciences Expertise

At BIO 2026, Maven Regulatory Solutions will connect with pharmaceutical, biotechnology, and healthcare organizations seeking comprehensive regulatory support across every stage of product development and commercialization.

Regulatory Affairs & Global Market Access

  • Global regulatory strategy and market entry planning
  • CTD, eCTD, NeeS & ASEAN dossier preparation
  • Product registration and lifecycle management
  • Regulatory intelligence and compliance monitoring
  • CMC documentation and regulatory support
  • Global submissions across FDA, EMA, MHRA, TGA, Health Canada, GCC, ASEAN, LATAM & emerging markets

Biologics, Biosimilars & Advanced Therapies

  • Biologics regulatory strategy
  • Biosimilar product registration
  • Cell & Gene Therapy (CGT) regulatory support
  • ATMP regulatory consulting
  • Clinical development regulatory pathways
  • Expedited approval strategies

Pharmacovigilance & Drug Safety

  • End-to-end pharmacovigilance services
  • Signal detection and benefit-risk evaluation
  • Aggregate reporting
  • Risk Management Plans (RMP)
  • Literature monitoring
  • Global safety database support
  • Case processing and regulatory compliance

Clinical & Regulatory Operations

  • Clinical trial regulatory support
  • IND, CTA & clinical submission support
  • Inspection readiness programs
  • Regulatory gap assessments
  • GxP compliance consulting
  • Quality Management Systems (QMS)
  • Regulatory documentation management

Digital Regulatory Transformation

  • Regulatory Information Management Systems (RIMS)
  • AI-enabled regulatory operations
  • Digital document management
  • Regulatory workflow automation
  • Data governance and compliance
  • Technology-driven regulatory intelligence
  • Regulatory process optimization

Key Industry Topics Driving BIO 2026

The BIO International Convention 2026 will focus on several transformative areas shaping the future of biotechnology and pharmaceutical innovation, including:

  • Artificial Intelligence in Drug Discovery
  • Cell & Gene Therapy Commercialization
  • Business Development & Strategic Partnerships
  • Licensing & Investment Opportunities
  • Precision Medicine
  • Biologics & Biosimilars
  • Next-Generation Therapeutics
  • Brain Health & Neuroscience Innovation
  • Metabolic Disease Research Beyond GLP-1
  • Digital Health & Regulatory Innovation
  • Global Regulatory Harmonization
  • Future Biotech Investment Trends

Meet Maven at BIO 2026

BIO International Convention 2026 provides an outstanding opportunity to connect with Maven's regulatory experts and discuss strategies for accelerating innovation while ensuring global regulatory compliance.

Whether you're developing innovative biologics, biosimilars, advanced therapies, pharmaceuticals, or digital health solutions, Maven offers comprehensive regulatory expertise that supports successful product development, market authorization, lifecycle management, and worldwide commercialization.

Our participation reflects Maven's continued commitment to helping pharmaceutical and biotechnology organizations navigate complex regulatory landscapes through scientific excellence, regulatory intelligence, pharmacovigilance, clinical compliance, and digital transformation.

We look forward to meeting industry professionals, innovators, investors, and strategic partners at BIO International Convention 2026 in San Diego, California.

Why Meet Maven?

By meeting with Maven Regulatory Solutions, you can explore:

  • Global Regulatory Affairs Consulting
  • FDA, EMA & International Regulatory Strategy
  • CTD & eCTD Submission Services
  • Product Registration & Lifecycle Management
  • Pharmacovigilance Solutions
  • Clinical Regulatory Support
  • Biologics & Biosimilars Regulatory Consulting
  • Cell & Gene Therapy Regulatory Expertise
  • AI-Driven Regulatory Operations
  • Regulatory Intelligence & Compliance
  • Digital Regulatory Transformation
  • Global Market Access Strategy